| scholarly article | Q13442814 |
| P2093 | author name string | Hopkins A | |
| P2860 | cites work | Newly diagnosed primary intracranial neoplasms in pregnant women: a population-based assessment | Q30495908 |
| Change of seizure frequency in pregnant epileptic women | Q33619066 | ||
| Genetic predisposition to phenytoin-induced birth defects | Q34558227 | ||
| Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels | Q34620875 | ||
| The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967 | Q34726303 | ||
| Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. | Q34994741 | ||
| The relapsing course of certain meningiomas in relation to pregnancy and menstruation | Q37150724 | ||
| The fetal hydantoin syndrome | Q39338123 | ||
| Current concepts. Seizure disorders and pregnancy | Q39813966 | ||
| The epileptic mother and her child | Q40263288 | ||
| Precursor prothrombin status in patients receiving anticonvulsant drugs | Q42158147 | ||
| Spina bifida and in-utero exposure to valproate | Q42591453 | ||
| Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients | Q44669789 | ||
| Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan | Q47880779 | ||
| Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy. | Q51810703 | ||
| Maternal barbiturate utilization and neonatal withdrawal symptomatology | Q67275677 | ||
| Phenytoin and phenobarbitone plasma clearance during pregnancy | Q67524764 | ||
| A register study of maternal epilepsy and delivery outcome with special reference to drug use | Q69534310 | ||
| Phenytoin kinetics during pregnancy and the puerperium | Q69684991 | ||
| Pregnancy complications and outcomes in a cohort of women with epilepsy | Q69806031 | ||
| Salivary drug measurement: a cautionary tale | Q69890595 | ||
| Facial clefts in sibs and children of epileptic patients | Q70021172 | ||
| Thyroid function in epileptic mothers and their infants at birth | Q70067546 | ||
| Discordant expression of fetal hydantoin syndrome in heteropaternal dizygotic twins | Q70379651 | ||
| Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites | Q70471745 | ||
| Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs | Q70613187 | ||
| Bioavailability and pharmacokinetics of phenytoin during pregnancy | Q70644723 | ||
| Anticonvulsant drug therapy in human pregnancy: Effects on serum concentrations of vitamin D metabolites in maternal and cord blood | Q72395734 | ||
| Decreased serum protein binding of phenytoin in late pregnancy | Q72428920 | ||
| Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother | Q72526653 | ||
| Obstetric outcome in women with epilepsy | Q93588599 | ||
| P433 | issue | 6570 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 497-501 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Prescribing in pregnancy. Epilepsy and anticonvulsant drugs | |
| P478 | volume | 294 |
Search more.